Regenicin EBITDA vs. Book Value Per Share
| RGIN Stock | USD 0.0001 0.00 0.00% |
For Regenicin profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Regenicin to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Regenicin utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Regenicin's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Regenicin over time as well as its relative position and ranking within its peers.
Regenicin |
Regenicin Book Value Per Share vs. EBITDA Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Regenicin's current stock value. Our valuation model uses many indicators to compare Regenicin value to that of its competitors to determine the firm's financial worth. Regenicin is currently regarded as top stock in ebitda category among its peers. It also is currently regarded as top stock in book value per share category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Regenicin by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Regenicin's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Regenicin Book Value Per Share vs. EBITDA
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Regenicin |
| = | (655.96 K) |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Regenicin |
| = | (0.04) X |
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
Regenicin Book Value Per Share Comparison
Regenicin is currently under evaluation in book value per share category among its peers.
Regenicin Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Regenicin, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Regenicin will eventually generate negative long term returns. The profitability progress is the general direction of Regenicin's change in net profit over the period of time. It can combine multiple indicators of Regenicin, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Regenicin, Inc. focuses on developing and commercializing a technology of tissue-engineered skin substitutes. Regenicin, Inc. was incorporated in 2007 and is headquartered in Little Falls, New Jersey. Regenicin operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 3 people.
Regenicin Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Regenicin. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Regenicin position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Regenicin's important profitability drivers and their relationship over time.
Use Regenicin in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Regenicin position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regenicin will appreciate offsetting losses from the drop in the long position's value.Regenicin Pair Trading
Regenicin Pair Trading Analysis
The ability to find closely correlated positions to Regenicin could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Regenicin when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Regenicin - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Regenicin to buy it.
The correlation of Regenicin is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Regenicin moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Regenicin moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Regenicin can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Regenicin position
In addition to having Regenicin in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Entertainment Thematic Idea Now
Entertainment
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Entertainment theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Entertainment Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Regenicin Pink Sheet
To fully project Regenicin's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Regenicin at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Regenicin's income statement, its balance sheet, and the statement of cash flows.